| Term | Abbreviation |
| Afterdischarges | AD |
| Anterior thalamic nucleus | ATN |
| Anti-seizure medications | ASMs |
| Area under the curve | AUC |
| Brief pulse stimuli | BPS |
| Centromedian nucleus | CMN |
| Computed tomography | CT |
| Convolutional neural network | CNN |
| Deep brain stimulation | DBS |
| Drug-resistant epilepsy | DRE |
| Electrocorticography | ECoG |
| Electroencephalography | EEG |
| Epilepsy monitoring unit | EMU |
| Epileptogenic focus | EF |
| Food and Drug Administration | FDA |
| Interictal epileptiform activity | IEA |
| Intracranial electroencephalography | iEEG |
| Long-term treatment | LTT |
| Magnetic resonance-guided laser-interstitial thermal therapy | MR-guided LITT |
| Magnetic resonance imaging | MRI |
| Magnetoencephalogram | MEG |
| Mesial temporal lobe epilepsy | MTLE |
| Odds ratio | OR |
| Patient data management system | PDMS |
| Positron emission tomography | PET |
| Principal component analysis | PCA |
| Responsive neurostimulation | RNS |
| Seizure onset zone | SOZ |
| Stereotactic electroencephalography | SEEG |
| Support vector machine | SVM |
| Temporal lobe epilepsy | TLE |